ArticleInternational journal of clinical oncology2026
Comparison of effectiveness and safety of pembrolizumab plus lenvatinib versus nivolumab plus cabozantinib for metastatic renal cell carcinoma: a real-world study.
Taisuke Tobe et al.PubMed ↗Publisher ↗
No numbers read from the abstract.